Medical News

RSS

SARS-CoV-2 infection patterns in olfactory epithelium

Researchers assess changes in the respiratory and olfactory epithelium of the nasal mucosa in SARS-CoV-2 infections by the WA1, Delta, and Omicron strains.

18 Apr 2022

SARS-CoV-2 RBD is a selective integrin agonist

Researchers assess the Arg-Gly-Asp (RGD) motif-mediated binding of the SARS-CoV-2 RBD and integrin receptors.

18 Apr 2022

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Researchers demonstrate that avasimibe-mediated inhibition of ACAT blocks the entry and fusion of SARS-CoV-2 in different cell types.

18 Apr 2022

Impact of COVID-19 booster vaccination campaign in Israel

Researchers assess the implications of the COVID-19 booster vaccine on the Israeli population.

18 Apr 2022

New insight into lymphoid cell maturity could pave the way for more effective IBD treatments

A research group at Karolinska Institutet in Sweden has analyzed how certain immune cells known as innate lymphoid cells (ILCs) develop into mature cells that play a part in inflammatory bowel disease (IBD).

15 Apr 2022

Study pinpoints the reasons behind racial and ethnic gaps in Medicare’s quality program

For the past 10 years, the Medicare system has tried to improve the quality of health care that millions of older Americans receive, while slowing the growth in costs to the federal budget, by encouraging health care providers to join Accountable Care Organizations.

15 Apr 2022

Delivery technologies of mRNA and pDNA for advanced therapeutic applications

Innovation Center of NanoMedicine (Center Director: Prof. Kazunori Kataoka) has announced that Prof. Satoshi Uchida (Principal Research Scientist), who is also Associated Professor of the Kyoto Prefectural University of Medicine, published an article review about non-viral messenger RNA (mRNA) and plasmid DNA (pDNA) delivery by addressing the various delivery technologies of mRNA and pDNA, from basic research to therapeutic and clinical application; Pharmaceutics 2022, 14(4), 810.

15 Apr 2022

Role of cGAS-STING in SARS-CoV-2 infection

A new study analyzes the activation of cGAS and STING can induce a type I IFN response due to SARS-CoV-2 infection.

15 Apr 2022

Durable neutralizing response against Omicron after heterologous vaccine boosting

Researchers assess the impact of homologous and heterologous primary-booster vaccine dose combinations.

15 Apr 2022

Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

A recent study characterized the SARS-CoV-2 lineages circulating in Papua New Guinea during the second wave of COVID-19.

15 Apr 2022

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Researchers investigated the longevity and intensity of the SARS-CoV-2 vaccine immune response in patients suffering from immune-mediated inflammatory diseases.

15 Apr 2022

Breakthrough finding reveals how male sex hormones contribute to cancer-related sex bias

Patients with cancers stemming from non-reproductive organs, such as bladder and liver cancer, have striking discrepancies in incidence, progression, response to treatment and survival outcomes depending on their sex. In almost all cases, male patients have worse prognoses and outcomes.

15 Apr 2022

How the test-to-treat pillar of the US covid strategy is failing patients

The federal "test-to-treat" program, announced in March, is meant to reduce covid hospitalizations and deaths by quickly getting antiviral pills to people who test positive. But even as cases rise again, many Americans don't have access to the program.

15 Apr 2022

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

A new study examined the serological immune responses and antibody-dependent cell-mediated phagocytosis in individuals who had either received two doses of a standard vaccine regime, a booster dose following the regime, or a breakthrough infection following vaccination.

15 Apr 2022

Insight into the future of genetic testing

In this interview, we speak to Sheetal Parmar, vice president of medical affairs and head of clinical services at Natera, about their cell-free DNA (cfDNA) testing services.

From Natera 15 Apr 2022

Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

...

15 Apr 2022

Researchers track COVID-fighting antibodies after vaccination

The antibodies generated by Pfizer's COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health.

15 Apr 2022

COVID-19 vaccine offers protection for pregnant women and newborns

Pregnant women continue to have reservations about getting vaccinated against COVID-19 despite research indicating the safety of the vaccines and the protection they may offer their unborn children.

15 Apr 2022

Effects of COVID-19 treatment best with combination therapy

There is a steadily growing arsenal of drugs for COVID-19. Researchers from Charité – Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC) and Freie Universität (FU) Berlin have studied the mechanisms of action of antiviral and anti-inflammatory drugs.

15 Apr 2022

Acute stroke associated with considerable loss in life expectancy

Almost two-thirds of acute stroke patients fail to survive more than a decade and have high risk of recurrence, prompting researchers to call for better patient care.

15 Apr 2022

Medical News

SARS-CoV-2 infection patterns in olfactory epithelium

SARS-CoV-2 RBD is a selective integrin agonist

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Impact of COVID-19 booster vaccination campaign in Israel

New insight into lymphoid cell maturity could pave the way for more effective IBD treatments

Study pinpoints the reasons behind racial and ethnic gaps in Medicare’s quality program

Delivery technologies of mRNA and pDNA for advanced therapeutic applications

Role of cGAS-STING in SARS-CoV-2 infection

Durable neutralizing response against Omicron after heterologous vaccine boosting

Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Breakthrough finding reveals how male sex hormones contribute to cancer-related sex bias

How the test-to-treat pillar of the US covid strategy is failing patients

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

Insight into the future of genetic testing

Comparison of breakthrough infections in healthcare workers between 3 and 4-dose BNT162b2 vaccine recipients

Researchers track COVID-fighting antibodies after vaccination

COVID-19 vaccine offers protection for pregnant women and newborns

Effects of COVID-19 treatment best with combination therapy

Acute stroke associated with considerable loss in life expectancy

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News